Priya R. Prabhu - Concepedia

Author

Priya R. Prabhu

Rajiv Gandhi Centre for Biotechnology ORCID

Also Known As

Leeya Pinder, P Prabhu, Priya Prabhu, Priya R Prabhu, Priya R. Prabhu, Priya Ramesh Prabhu

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Rajiv Gandhi Centre for Biotechnology Centre international de recherche sur le cancer All India Institute of Medical Sciences Institute of Medical Sciences Heidelberg University

About

Priya R. Prabhu is an author at Rajiv Gandhi Centre for Biotechnology specializing in human papillomavirus vaccines, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	50
2	Public Health	1	1	26
3	Cell Biology	1	1	24
4	Epidemiology	1	1	26
5	Immunology	1	1	26

Priya R. Prabhu

Publications

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study Rengaswamy Sankaranarayanan, Priya R. Prabhu, Michael Pawlita, The Lancet Oncology	2015	244
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study Partha Basu, Sylla G. Malvi, Smita Joshi, The Lancet Oncology	2021	243
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study Rengaswamy Sankaranarayanan, Smita Joshi, Richard Muwonge, Vaccine	2018	163
Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent Vineshkumar Thidil Puliyappadamba, Vino T. Cheriyan, Arun Kumar T. Thulasidasan, Molecular Cancer	2010	57
Status of cancer screening in India: An alarm signal from the National Family Health Survey (NFHS-5) M G Gopika, Priya R. Prabhu, Jissa Vinoda Thulaseedharan Journal of Family Medicine and Primary Care	2022	55
Role of mucosal high‐risk human papillomavirus types in head and neck cancers in central India Tarik Gheit, Devasena Anantharaman, Dana Holzinger, International Journal of Cancer	2017	48
Postprandial Metabolism is Impaired in Overweight Normoglycemic Young Adults without Family History of Diabetes Ashok Kumar, Gopika Satheesh, Gadadharan Vijayakumar, Scientific Reports	2020	47
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines Filipe Colaço Mariz, Noemi Bender, Devasena Anantharaman, npj Vaccines	2020	44
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study Partha Basu, Richard Muwonge, Neerja Bhatla, Papillomavirus Research	2019	32
Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose in young women aged 15–20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials Kathy Baisley, Troy J. Kemp, Nelly Mugo, The Lancet Global Health	2024	31

Page 1